North America DNA Diagnostics Market By Product Type (Instruments, Reagents, Service & Software), Application (Oncology, Infectious Disease Testing, Myogenic Disorder Diagnosis, Clinical Confirmation, Prenatal Diagnosis, Pre-implantation), Technology (PCR, Microarrays, In situ hybridization, Sequencing Technology, Mass Spectrometry), End User
Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
Get in-depth analysis of the COVID-19 impact on the North America DNA Diagnostics Market
DNA diagnostics is relatively a mature market; therefore, the diagnostic technique and tools have been widely adopted in various applications such as infectious diseases, oncology, myogenic disorders, prenatal diagnostics, pre-implantation diagnostics and clinical diagnostic confirmation. The growing incidences of cancer around the world has driven the oncology market globally. The oncology segment of North America DNA Diagnostics Market is expected to grow at a CAGR of 11.6% during the forecast period. Growing awareness about healthcare, and the need for cost effective diagnostic solutions & accurate & faster test results in the fast growing economies have contributed to the growth of the market. Additionally, rising incidences of chronic and infectious diseases, demand for automated instruments and growing governments expenditures for providing healthcare facilities are also contributing to the growth of the DNA diagnostics market. Lack of reimbursement policies and high priced products are some of the factors that restrict the market growth.
The report highlights the adoption of DNA Diagnostics in North America. Based on the Product Types, the North America DNA Diagnostics Market is segmented into Instruments, Reagents and Service & software segment. Based on the Application, the market is bifurcated into Oncology, Infectious disease testing, Myogenic disorder diagnosis, Clinical confirmation diagnostics, Prenatal diagnosis, Pre-implantation diagnostics and other segments. Based on the Technology, the market is bifurcated into PCR, Microarrays, In situ hybridization, Sequencing Technology, Mass Spectrometry and other segments. Further, the market is segmented into POC (Point-of-Care), Central Laboratories and Self-Testing segments based on the End Users. The countries included in the report are U.S, Canada, Mexico and Rest of North America.
Key Players profiled in the report includes Sysmex Corporation, Bayer Corporation, Roche Diagnostics, Abbott Laboratories, Cepheid Inc, Hologic Corporation, Illumina, Novartis International Ag, Thermo Fisher Scientific Inc. and Bio-Rad Laboratories.